Evaluation of sphingolipids in Wistar rats treated to prolonged and single oral doses of fumonisin b₁

Int J Mol Sci. 2009 Jan;10(1):50-61. doi: 10.3390/ijms10010050. Epub 2008 Dec 27.

Abstract

The objective of the present study was to evaluate sphingolipid levels (sphingosine-So and sphinganine-Sa) and to compare the Sa/So ratio in liver, serum and urine of Wistar rats after prolonged administration (21 days) of fumonisin B(1) (FB(1)). In parallel, the kinetics of sphingolipid elimination in urine was studied in animals receiving a single dose of FB(1). Prolonged exposure to FB(1) caused an increase in Sa levels in urine, serum and liver. The most marked effect on sphingolipid biosynthesis was observed in animals treated with the highest dose of FB(1). Animals receiving a single dose of FB(1) presented variations in Sa and So levels and in the Sa/So ratio.

Keywords: Fumonisin B1; Wistar rats; biomarkers; prolonged effect; single dose; sphingolipids.

MeSH terms

  • Administration, Oral
  • Animals
  • Fumonisins / administration & dosage
  • Fumonisins / pharmacology*
  • Liver / drug effects
  • Liver / metabolism
  • Rats
  • Rats, Wistar
  • Sphingosine / analogs & derivatives*
  • Sphingosine / blood
  • Sphingosine / metabolism
  • Sphingosine / urine

Substances

  • Fumonisins
  • Sphingosine
  • safingol